🔎 Trials Near Me

Home › Kanser sa Pancreas › Pennsylvania › Pittsburgh

Pag-aaral pangklinika para sa Kanser sa Pancreas sa Pittsburgh, PA

Isang pag-aaral para sa Kanser sa Pancreas ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Pittsburgh. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Nagre-recruitPhase 1
  • UPMC Hillman Cancer Center, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05372614

Distance-Based Exercise to Preserve Function and Prevent Disability

Nagre-recruit
  • UPMC Hillman Cancer Center, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07059884

Pancreatic Cancer Detection Consortium

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • AHN Cancer Institute at Allegheny General Hospital, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06388967

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

Nagre-recruitPhase 3
  • UPMC Hillman Cancer Center, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07252232

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Nagre-recruitPhase 3
  • Investigative Site US056, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07522073

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

Nagre-recruitPhase 3
  • AGH Singer Research Institute, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07409272

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2
  • Allegheny Health Network, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

Nagre-recruitObservasyonal na pag-aaral
  • University of Pittsburgh, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06271291

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Nagre-recruitObservasyonal na pag-aaral
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Hanggang edad 17 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06651580

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Nagre-recruitObservasyonal na pag-aaral
  • Bryn Mawr Hospital, Bryn Mawr · 11 mi ang layo
Edad 50 hanggang 75 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT04239573

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Nagre-recruitPhase 1/2
  • UPMC Hillman Cancer Center, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT04172532

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Nagre-recruitPhase 3
  • Allegheny General Hospital, Pittsburgh
  • West Penn Hospital, Pittsburgh
  • Jefferson Hospital, Jefferson Hills · 11 mi ang layo
  • at 1 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06958328

Pancreatic Cancer Early Detection Consortium

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • University of Pittsburgh Medical Center (Upmc), Pittsburgh
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT04970056

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

Nagre-recruitPhase 1
  • UPMC Hillman Cancer Center, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 8, 2026 · NCT04890613

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

Nagre-recruitPhase 2
  • Allegheny General Hospital, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 3, 2026 · NCT06850623

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Nagre-recruitObservasyonal na pag-aaral
  • Allegheny Health Network, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT04075305

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Nagre-recruitPhase 2
  • Ohio State University-Telemedicine, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT06906562

Pancreatic Adenocarcinoma Gene Environment Risk Study

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • University of Pittsburgh, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 19, 2025 · NCT00912717

The Cancer of the Pancreas Screening-5 CAPS5)Study

Nagre-recruitPhase 3
  • University of Pittsburgh, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 9, 2025 · NCT02000089

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Nagre-recruitPhase 1
  • UPMC Hillman Cancer Center, Pittsburgh
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 15, 2025 · NCT04429542

Pag-aaral para sa Kanser sa Pancreas sa ibang lungsod

Iba pang pag-aaral sa Pittsburgh

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.